LTGO-33
LTGO-33 is a species-specific inhibitor of the voltage-gated sodium channel NaV1.8, inhibiting NaV1.8, NaV1.1-NaV1.7, and NaV1.9.LTGO-33 inhibits wild-type and multiple NaV1.8 variants associated with human pain disorders and can be used for the study of pain.hBChE-IN-2 is a low affinity Nurr1 agonist.
Product Specifications
CAS Number
2834106-06-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
467.44
Molecular Formula
C21H17F4N3O3S
Notes
Research use only, not for human use.
Receptor
Sodium Channel
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FM169781 5000 mg
2- ((4-methylphenyl) sulfonyl) -3- (phenylamino) -3-sulfanylprop-2-enenitrile
Sign In for Pricing
View Details 
MBS4380851-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
EGFR (Epidermal Growth Factor Receptor)
Sign In for Pricing
View Details MBS4380851-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
EGFR (Epidermal Growth Factor Receptor)
Sign In for Pricing
View Details MBS4380851-03 0.1 mg (Without BSA & Azide at 1mg/mL)
EGFR (Epidermal Growth Factor Receptor)
Sign In for Pricing
View Details MBS4380851-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
EGFR (Epidermal Growth Factor Receptor)
Sign In for Pricing
View Details MBS4380851-05 5x 0.1 mg (Without BSA & Azide at 1mg/mL)
EGFR (Epidermal Growth Factor Receptor)
Sign In for Pricing
View Details